Early research (Phase 1)Study completedNCT06389578What this trial is testingTEPEZZA® Treatment in Participants With Thyroid Eye DiseaseWho this might be right forThyroid Eye Disease Amgen 16
Large-scale testing (Phase 3)Active Not RecruitingNCT06625398What this trial is testingAn Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)Who this might be right forThyroid Eye Disease Viridian Therapeutics, Inc. 204
Large-scale testing (Phase 3)Not Yet RecruitingNCT07622108What this trial is testingTreatment of Active Thyroid Eye Disease With MHB018A in a Randomized, Placebo-Controlled StudyWho this might be right forThyroid Eye Disease, TED Minghui Pharmaceutical (Hangzhou) Ltd 84
Large-scale testing (Phase 3)Looking for participantsNCT03131726What this trial is testingTreatment of Graves´ophthalmopathy with Simvastatin (GO-S)Who this might be right forGraves OphthalmopathyThyroid Associated OphthalmopathyThyroid Associated Orbitopathy Lund University 80
Not applicableStudy completedNCT02693808What this trial is testingNew Treatment for Patients With Temporal Hollowing After Lateral Wall DecompressionWho this might be right forThyroid-Associated Ophthalmopathy Haukeland University Hospital 29
Not applicableStudy completedNCT00348413What this trial is testingThyroid Treatment TrialWho this might be right forGraves Ophthalmopathy Singapore National Eye Centre 80
Large-scale testing (Phase 3)Active Not RecruitingNCT06812325What this trial is testingA Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)Who this might be right forThyroid Eye Disease (TED) Viridian Therapeutics, Inc. 320
Not applicableStudy completedNCT03590080What this trial is testingImpact of Intravenous Methylprednisolone Treatment on Blood PressureWho this might be right forGraves DiseaseGraves OphthalmopathyHypertension+2 more Medical University of Warsaw 32
Large-scale testing (Phase 3)Active Not RecruitingNCT07211776What this trial is testingAssess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye DiseaseWho this might be right forThyroid Eye Disease (TED) Zai Lab (Shanghai) Co., Ltd. 108
Large-scale testing (Phase 3)Study completedNCT00595335What this trial is testingTrial of Rituximab for Graves' OphthalmopathyWho this might be right forThyroid-associated Ophthalmopathy Rebecca Bahn 25
Early research (Phase 1)Ended earlyNCT06467435What this trial is testingEvaluation of K9 in Subjects With Thyroid Eye Disease (TED)Who this might be right forThyroid Eye Disease Peter Timoney 4
Testing effectiveness (Phase 2)Study completedNCT01868997What this trial is testingTeprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye DiseaseWho this might be right forThyroid Associated OphthalmopathiesThyroid-Associated Ophthalmopathy Amgen 88
Not applicableLooking for participantsNCT01793168What this trial is testingRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordWho this might be right forRare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more Sanford Health 20,000
Large-scale testing (Phase 3)WithdrawnNCT02422368What this trial is testingThe Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye DiseaseWho this might be right forThyroid Eye Disease Iran University of Medical Sciences
Large-scale testing (Phase 3)Active Not RecruitingNCT06248619What this trial is testingA Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye DiseaseWho this might be right forThyroid Eye Disease Amgen 89
Testing effectiveness (Phase 2)WithdrawnNCT01379196What this trial is testingUse of Azithromycin as Immunomodulatory Therapy in Grave&Apos;s OrbitopathyWho this might be right forGraves Ophthalmopathy Rabin Medical Center
Early research (Phase 1)Study completedNCT07142642What this trial is testingEvaluate Pharmacokinetics, Safety, and Tolerability of Teprotumumab (AMG 632) Administered Intravenously in Healthy Chinese ParticipantsWho this might be right forHealthy Volunteers Amgen 20
Large-scale testing (Phase 3)Study completedNCT06021054What this trial is testingAn Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)Who this might be right forThyroid Eye Disease Viridian Therapeutics, Inc. 188
Not applicableUnknownNCT03447093What this trial is testingThe Oral Microbiota is Associated With Autoimmune ThyroiditisWho this might be right forMicrobiota First Affiliated Hospital of Harbin Medical University 120
Large-scale testing (Phase 3)Study completedNCT01297699What this trial is testingTocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)Who this might be right forThyroid Associated OphthalmopathiesGraves´ OphthalmopathyThyroid Eye Disease Hospital Clinico Universitario de Santiago 32